Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BRCA1 in hormone-responsive cancers.

Eliot M Rosen1, Saijun Fan, Richard G Pestell

  • 1Department of Oncology, Lombardi Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20057, USA. emr36@georgetown.edu

Trends in Endocrinology and Metabolism: TEM
|October 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burden of Central Nervous System Cancer in the United States, 1990-2021.

JAMA neurology·2025
Same author

PPARγ acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding.

Oncogene·2025
Same author

Targeting WEE1 Kinase for Breast Cancer Therapeutics: An Update.

International journal of molecular sciences·2025
Same author

Role of GPCR Signaling in Anthracycline-Induced Cardiotoxicity.

Cells·2025
Same author

Editorial Expression of Concern: Role of BRCA1 in heat shock response.

Oncogene·2024
Same author

A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription.

Oncogenesis·2024

Mutations in the breast cancer gene BRCA1 increase risks for early-onset breast and ovarian cancers. BRCA1 also impacts hormone-driven cancers by interacting with estrogen and androgen receptors.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the breast cancer gene BRCA1 are associated with hereditary breast and ovarian cancer syndromes.
  • BRCA1 mutations increase the risk of early-onset breast and ovarian cancers, as well as other hormone-dependent cancers like uterine, cervical, and prostate cancers.
  • Reduced BRCA1 expression in sporadic breast and ovarian cancers suggests a broader role in tumorigenesis.

Purpose of the Study:

  • To investigate the broader role of BRCA1 in hormone-dependent cancers.
  • To explore the molecular mechanisms linking BRCA1 to hormone receptor signaling.
  • To understand why BRCA1 mutation carriers develop hormone-responsive cancers.

Main Methods:

  • Review of existing literature on BRCA1 function and its role in cancer.

Related Experiment Videos

  • Analysis of studies investigating BRCA1 interactions with hormone receptors.
  • Examination of BRCA1 expression patterns in sporadic and hereditary cancers.

    • Main Results:

    • BRCA1 plays a role in DNA repair, cell-cycle progression, and apoptosis, consistent with tumor suppressor activity.
    • BRCA1 interacts with and regulates the activity of estrogen receptor alpha (ER alpha) and androgen receptor.
    • BRCA1 expression is influenced by signaling pathways involving carcinogens and anticarcinogens.

    Conclusions:

    • BRCA1's interaction with hormone receptors provides a molecular link to hormone-responsive cancers.
    • The findings suggest BRCA1 has a significant role beyond DNA repair in the development of various hormone-dependent cancers.
    • Further research into BRCA1's regulatory functions may reveal new therapeutic targets for hormone-driven malignancies.